These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 21709296)
1. Changes over time in glycemic control, insulin sensitivity, and beta-cell function in response to low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance. Retnakaran R; Qi Y; Harris SB; Hanley AJ; Zinman B Diabetes Care; 2011 Jul; 34(7):1601-4. PubMed ID: 21709296 [TBL] [Abstract][Full Text] [Related]
2. Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study. Zinman B; Harris SB; Neuman J; Gerstein HC; Retnakaran RR; Raboud J; Qi Y; Hanley AJ Lancet; 2010 Jul; 376(9735):103-11. PubMed ID: 20605202 [TBL] [Abstract][Full Text] [Related]
3. Discordant effects on central obesity, hepatic insulin resistance, and alanine aminotransferase of low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance. Retnakaran R; Ye C; Hanley AJ; Harris SB; Zinman B Diabetes Obes Metab; 2012 Jan; 14(1):91-3. PubMed ID: 21812893 [TBL] [Abstract][Full Text] [Related]
4. Effects of metformin and rosiglitazone on peripheral insulin resistance and β-cell function in obesity: a double-blind, randomized, controlled study. Li X; Zhang N; Li Y; Shi Y; Li D; Xie Y; Xie Y; Ming J J Int Med Res; 2011; 39(2):358-65. PubMed ID: 21672339 [TBL] [Abstract][Full Text] [Related]
5. Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone. Osei K; Gaillard T; Schuster D Metabolism; 2007 Jan; 56(1):24-9. PubMed ID: 17161222 [TBL] [Abstract][Full Text] [Related]
6. Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT. Kahn SE; Lachin JM; Zinman B; Haffner SM; Aftring RP; Paul G; Kravitz BG; Herman WH; Viberti G; Holman RR; Diabetes; 2011 May; 60(5):1552-60. PubMed ID: 21415383 [TBL] [Abstract][Full Text] [Related]
7. Effect of Rosiglitazone and Ramipril on {beta}-cell function in people with impaired glucose tolerance or impaired fasting glucose: the DREAM trial. Hanley AJ; Zinman B; Sheridan P; Yusuf S; Gerstein HC; Diabetes Care; 2010 Mar; 33(3):608-13. PubMed ID: 20009095 [TBL] [Abstract][Full Text] [Related]
8. What's next for diabetes prevention? Kahn SE; Utzschneider KM Diabetes Care; 2011 Jul; 34(7):1678-80. PubMed ID: 21709302 [No Abstract] [Full Text] [Related]
9. Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Retnakaran R; Shen S; Hanley AJ; Vuksan V; Hamilton JK; Zinman B Obesity (Silver Spring); 2008 Aug; 16(8):1901-7. PubMed ID: 18551118 [TBL] [Abstract][Full Text] [Related]
10. Effect of metformin and rosiglitazone in a prepubertal boy with Alström syndrome. Sinha SK; Bhangoo A; Anhalt H; Maclaren N; Marshall JD; Collin GB; Naggert JK; Ten S J Pediatr Endocrinol Metab; 2007 Sep; 20(9):1045-52. PubMed ID: 18038714 [TBL] [Abstract][Full Text] [Related]
11. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY. TODAY Study Group Diabetes Care; 2013 Jun; 36(6):1749-57. PubMed ID: 23704674 [TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone maleate/metformin hydrochloride: a new formulation therapy for type 2 diabetes. Cox SL Drugs Today (Barc); 2004 Jul; 40(7):633-43. PubMed ID: 15510236 [TBL] [Abstract][Full Text] [Related]
13. Effects of exenatide plus rosiglitazone on beta-cell function and insulin sensitivity in subjects with type 2 diabetes on metformin. DeFronzo RA; Triplitt C; Qu Y; Lewis MS; Maggs D; Glass LC Diabetes Care; 2010 May; 33(5):951-7. PubMed ID: 20107105 [TBL] [Abstract][Full Text] [Related]
14. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes. Kadoglou NP; Kapelouzou A; Tsanikidis H; Vitta I; Liapis CD; Sailer N Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):63-8. PubMed ID: 21031343 [TBL] [Abstract][Full Text] [Related]
15. Effect of rosiglitazone and metformin on insulin resistance in patients infected with human immunodeficiency virus receiving highly active antiretroviral therapy containing protease inhibitor: randomized prospective controlled clinical trial. Silic A; Janez A; Tomazic J; Karner P; Vidmar L; Sharma P; Maticic M Croat Med J; 2007 Dec; 48(6):791-9. PubMed ID: 18074413 [TBL] [Abstract][Full Text] [Related]
16. Preventing type 2 diabetes using combination therapy: design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trial. Zinman B; Harris SB; Gerstein HC; Young TK; Raboud JM; Neuman J; Hanley AJ Diabetes Obes Metab; 2006 Sep; 8(5):531-7. PubMed ID: 16918588 [TBL] [Abstract][Full Text] [Related]
17. Impact of Insulin and Metformin Versus Metformin Alone on β-Cell Function in Youth With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes. RISE Consortium Diabetes Care; 2018 Aug; 41(8):1717-1725. PubMed ID: 29941500 [TBL] [Abstract][Full Text] [Related]
18. Metformin/rosiglitazone combination pill (Avandamet) for the treatment of patients with Type 2 diabetes. Smiley D; Umpierrez G Expert Opin Pharmacother; 2007 Jun; 8(9):1353-64. PubMed ID: 17563269 [TBL] [Abstract][Full Text] [Related]
19. Impact of Gastric Banding Versus Metformin on β-Cell Function in Adults With Impaired Glucose Tolerance or Mild Type 2 Diabetes. Xiang AH; Trigo E; Martinez M; Katkhouda N; Beale E; Wang X; Wu J; Chow T; Montgomery C; Nayak KS; Hendee F; Buchanan TA; ; Diabetes Care; 2018 Dec; 41(12):2544-2551. PubMed ID: 30282699 [TBL] [Abstract][Full Text] [Related]
20. Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea. Triplitt C; Glass L; Miyazaki Y; Wajcberg E; Gastaldelli A; De Filippis E; Cersosimo E; DeFronzo RA Diabetes Care; 2006 Nov; 29(11):2371-7. PubMed ID: 17065670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]